Legalise psilocybin for adult recreational use in the UK through a tightly controlled licensing framework. Ensure products are tested for safety, consistently dosed, clearly labelled, age-restricted, and fully traceable from production to sale.

Psilocybin is used in varying doses, from microdoses to higher experiences, with anecdotal reports of improved mood, creativity, and perspective. Research suggests potential value in studying conditions like depression, PTSD, and anxiety in controlled settings. We believe a regulated adult framework could improve safety, consistency, and information, reduce illegal supply risks, and support public health guidance, education, and further research into both benefits and risks.